Evidence map›Paper›PMID 37419689›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2023

Regulation of the Ca

Kyle E Ireton, Xiaoming Xing, Karam Kim, Justin C Weiner, Ariel A Jacobi, Aarushi Grover, Molly Foote, Yusuke Ota, Robert Berman, Timothy Hanks and 1 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Deletion ofFrontiers in cellular neuroscience · 2026
    Article
  4. Stimulation of CaScience signaling · 2025
    Article
  5. Deletion ofbioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Kyle E IretonDepartment of Pharmacology, University of California, Davis, California 95616-8636.
Xiaoming XingDepartment of Pharmacology, University of California, Davis, California 95616-8636.
Karam KimDepartment of Pharmacology, University of California, Davis, California 95616-8636.
Justin C WeinerDepartment of Pharmacology, University of California, Davis, California 95616-8636.
Ariel A JacobiDepartment of Pharmacology, University of California, Davis, California 95616-8636.
Aarushi GroverDepartment of Pharmacology, University of California, Davis, California 95616-8636.
Molly FooteCenter for Neuroscience, University of California, Davis, California 95616-8636.
Yusuke OtaCenter for Neuroscience, University of California, Davis, California 95616-8636.
Robert BermanCenter for Neuroscience, University of California, Davis, California 95616-8636.
Timothy HanksCenter for Neuroscience, University of California, Davis, California 95616-8636 thanks@ucdavis.edu jwhell@ucdavis.edu.
Johannes W HellDepartment of Pharmacology, University of California, Davis, California 95616-8636 thanks@ucdavis.edu jwhell@ucdavis.edu.ORCID 0000-0001-7960-7531
University of California, Davis · USUniversity of California System · US

Funding

UC Davis MCB T32 Administrative Supplement to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) MentorshipT32GM007377 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI CHEDIN, FREDERIC LOUIS · 1985 to 2023
$9.9M
Role of a-actinin in Cav1.2 FunctionR01AG055357 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI JOHANNES W HELL · 2016 to 2026
$4.0M
SynDIG1/Prrt1 regulation of extrasynaptic GluA1-containing AMPARs during plasticityR01MH119347 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DIAZ, ELVA D, HELL, JOHANNES W · 2019 to 2024
$3.3M
Training Program in Basic NeuroscienceT32MH082174 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI W MARTIN USREY · 2007 to 2026
$3.1M
Learning, Memory, and Plasticity (LaMP) Training ProgramT32MH112507 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Karen Zito · 2017 to 2026
$2.4M
Postsynaptic Signaling by Norepinephrine and cAMPR01NS123050 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI JOHANNES W HELL · 2022 to 2026
$2.3M
Predoctoral Training in Pharmacological SciencesT32GM099608 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HELL, JOHANNES W · 2012 to 2021
$2.2M
Dysregulation of Cav1.2 by beta amyloid peptideRF1AG055357 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HELL, JOHANNES W · 2022 to 2024
$1.7M
NIA NIH HHS R01 AG055357NIA NIH HHS RF1 AG055357NIGMS NIH HHS T32 GM007377NIGMS NIH HHS T32 GM099608NIMH NIH HHS R01 MH119347NIMH NIH HHS T32 MH082174NIMH NIH HHS T32 MH112507NINDS NIH HHS R01 NS123050
6 · The paper itself

Abstract

Widespread release of norepinephrine (NE) throughout the forebrain fosters learning and memory via adrenergic receptor (AR) signaling, but the molecular mechanisms are largely unknown. The β

Indexed as

Neuronal PlasticitySpatial MemoryAnimalsCyclic AMP-Dependent Protein KinasesFemaleHippocampusLong-Term PotentiationMaleMicePhosphorylationSignal TransductionCyclic AMP-Dependent Protein Kinaseslong-term depressionL-type calcium channelsMorris water mazenorepinephrinereversal learningβ2 adrenergic receptor

Identifiers

PMID37419689
PMCPMC10376936
OpenAlexW4383499831

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.